RETRACTED: Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis

Biomed Pharmacother. 2018 Nov:107:547-554. doi: 10.1016/j.biopha.2018.08.020. Epub 2018 Aug 13.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and the authors. Figure 2D appears similar to Figure 2D of the article that Dongkai Zhao, Zhiyu Jiang, Zhihui Wang and Jinliang Gao have previously published in Biomedicine & Pharmacotherapy 98 (2018) 719-725 https://doi.org/10.1016/j.biopha.2017.12.114. However, the images purport to represent different experiments by separate author groups. The authors offer their apologies to the readers of the journal for any inconvenience this might have caused.

Keywords: LncRNA; Retinoblastoma; STAT3; XIST; miR-124.

Publication types

  • Retracted Publication

MeSH terms

  • Apoptosis / genetics
  • Base Sequence
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Child, Preschool
  • Disease Progression*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques*
  • Humans
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Retinoblastoma / genetics*
  • Retinoblastoma / pathology*
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism*
  • Signal Transduction
  • Up-Regulation / genetics

Substances

  • MIRN124 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • STAT3 Transcription Factor
  • XIST non-coding RNA